Geographical miss during centered intracoronary beta-radiation with 90Yttrium: Incidence and implications for recurrence rates after vascular brachytherapy for de novo lesions

International Journal of Cardiovascular Interventions

Volumn 5, Issue 4, 2003, Pages 181-189

  Sianos, Georgios ^a   Wijns, William ^b   De Feyter, Pim J ^a   Serruys, Patrick W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b CARDIOVASCULAR CENTER   (Belgium)

Author keywords

Geographical miss; Intracoronary radiation; Restenosis

Indexed keywords

YTTRIUM 90;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BETA RADIATION; BLOOD VESSEL DIAMETER; BRACHYTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; TREATMENT FAILURE;

BRACHYTHERAPY; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; CORONARY STENOSIS; CORONARY VESSELS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; RECURRENCE; RETROSPECTIVE STUDIES; YTTRIUM RADIOISOTOPES;

EID: 0346902189     PISSN: 14628848     EISSN: None     Source Type: Journal    
DOI: 10.1080/14628840310015223     Document Type: Article

References (56)

1. Holmes DR, Jr, Vlietstra RE, Smith HC et al. Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA registry of the National Heart Lung and Blood Institute. Am J Cardiol 1984; 53: 77C-81C.
2. Popma JJ, Califf RM, Topol EJ. Clinical trials of restenosis after coronary angioplasty. Circulation 1991; 84: 1426-1436.
3. Gruentzig AR, King SB III, Schlumpf M, Siegenthaler W. Long-term follow-up after percutaneous transluminal coronary angioplasty. N Engl J Med 1987; 316: 1127-1132.
4. Mintz GS, Popma JJ, Pichard AD et al. Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study. Circulation 1996; 94: 35-43.
5. Serruys PW, de Jaegere P, Kiemeneij F et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 1994; 331: 489-495.
6. Fischman DL, Leon MB, Baim DS et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med 1994; 331: 496-501.
7. Mintz GS, Mehran R, Waksman R et al. Treatment of instent restenosis. Semin Intervent Cardiol 1998; 3: 117-121.
8. Wiedermann IG, Marboe C, Amols H, Schwartz A, Weinberger J. Intracoronary irradiation markedly reduces restenosis after balloon angioplasty in a porcine model. J Am Coll Cardiol 1994; 23: 1491-1498.
9. Verin V, Popowski Y, Urban P et al. Intra-arterial beta irradiation prevents neointimal hyperplasia in a hypercholesterolemic rabbit restenosis model. Circulation 1995; 92: 2284-2290.
10. Waksman R, Robinson KA, Crocker IR, Gravanis MB, Cipolla GD, King SB III. Endovascular low-dose irradiation inhibits neointima formation after coronary artery balloon injury in swine. A possible role for radiation therapy in restenosis prevention. Circulation 1995; 9: 1533-1539.
11. Waksman R, Robinson KA, Crocker IR et al. Intracoronary radiation before stent implantation inhibits neointima formation in stented porcine coronary arteries. Circulation 1995; 92: 1383-1386.
12. Condado JA, Waksman R, Gurdiel O et al. Long-term angiographic and clinical outcome after percutaneous transluminal coronary angioplasty and intracoronary radiation therapy in humans. Circulation 1997; 96: 727-732.
13. King SB III, Williams DO, Chougule P et al. Endovascular beta-radiation to reduce restenosis after coronary balloon angioplasty: results of the beta energy restenosis trial (BERT). Circulation 1998; 97: 2025-2030.
14. Raizner AE, Oesterle SN, Waksman R et al. Inhibition of restenosis with beta-emitting radiotherapy: report of the Proliferation Reduction with Vascular Energy Trial (PREVENT). Circulation 2000; 102: 951-958.
15. Serruys P, Sianos G, van der Giessen W et al. Intracoronary beta-radiation to reduce restenosis after balloon angioplasty and stenting. The Beta Radiation In Europe (BRIE) study. Eur Heart J 2002; 23: 1351-1359.
16. Waksman R, Bhargava B, White L et al. Intracoronary beta-radiation therapy inhibits recurrence of in-stent restenosis. Circulation 2000; 101: 1895-1898.
17. Popma JJ, Suntharalingam M, Lansky AJ et al. Randomized trial of 90 Sr/ 90 Y β-radiation versus placebo control for treatment of in-stent restenosis. Circulation 2002; 106: 1090-1096.
18. Suntharalingam M, Laskey W, Lansky AJ et al. Clinical and angiographic outcomes after use of 90 Strondium/90 Yttrium beta radiation for the treatment of in-stent restenosis: results from the Stents And Radiation Therapy 40 (START 40) registry. Int J Radiat Oncol Biol Phys 2002; 52: 1075-1082.
19. Waksman R, Raizner AE, Yeung AC et al. Use of localised intracoronary β radiation in treatment of in-stent restenosis: the INHIBIT randomised controlled trial. Lancet 2002; 359: 551-557.
20. Teirstein PS, Massullo V, Jani S et al. A double-blinded randomized trial of catheter-based radiotherapy to inhibit restenosis following coronary stenting. N Engl J Med 1997; 336: 1697-1703.
21. Waksman R, White RL, Chan RC et al. Intracoronary gamma-radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis. Circulation 2000; 101: 2165-2171.
22. Leon MB, Teirstein PS, Moses JW et al. Localized intracoronary gamma radiation therapy to inhibit the recurrence of restenosis after stenting. N Engl J Med 2001; 344: 250-256.
23. Waksman R, Ajani AE, White RL et al. Intravascular gamma radiation for in-stent restenosis in saphenous-vein bypass grafts. N Engl J Med 2002; 346: 1194-1199.
24. Sabate M, Costa MA, Kozuma K et al. Geographic miss: a cause of treatment failure in radio-oncology applied to intracoronary radiation therapy. Circulation 2000; 101: 2467-2471.
25. Albiero R, Adamian M, Kobayashi N et al. Short- and intermediate-term results of (32)P radioactive beta-emitting stent implantation in patients with coronary artery disease: the Milan Dose-Response Study. Circulation 2000; 101: 18-26.
26. Costa MA, Sabate M, van der Giessen WJ et al. Late coronary occlusion after intracoronary brachytherapy. Circulation 1999; 100: 789-792.
27. Waksman R, Bhargava B, Mintz GS et al. Late total occlusion after intracoronary brachytherapy for patients with in-stent restenosis. J Am Coll Cardiol 2000; 36: 65-68.
28. Waksman R. Late thrombosis after radiation. Sitting on a time bomb. Circulation 1999; 100: 780-782.
29. Vodovotz Y, Waksman R, Kim WH, Bhargava B, Chan RC, Leon M. Effects of intracoronary radiation on thrombosis after balloon overstretch injury in the porcine model. Circulation 1999; 100: 2527-2533.
30. Kay IP, Sabate M, Van Langenhove G et al. Outcome from balloon-induced coronary artery dissection after intracoronary beta radiation. Heart 2000; 83: 332-337.
31. Meerkin D, Tardif JC, Bertrand OF, Vincent J, Harel F, Bonan R. The effects of intracoronary brachytherapy on the natural history of postangioplasty dissections. J Am Coll Cardiol 2000; 36: 59-64.
32. Paterson R, The Treatment of Malignant Disease by Radiotherapy. London, Edward Arnold, 1963.
33. Sianos G, Kay IP, Regar E et al. Geographical miss during catheter-based intracoronary beta radiation: incidence and implications in the BRIE study. J Am Coll Cardiol 2001; 38: 415-420.
34. Kim HS, Waksman R, Cottin Y et al. Edge stenosis and geographical miss following intracoronary gamma radiation therapy for in-stent restenosis. J Am Coll Cardiol 2001; 37: 1026-1030.
35. Syeda B, Siostrzonek P, Schmid R et al. Geographical miss during intracoronary irradiation: impact on restenosis and determination of required safety margin length. J Am Coll Cardiol 2002; 40: 1225-1231.
36. Verin V, Popowski Y, de Bruyne B et al. Endoluminal beta-radiation therapy for the prevention of coronary restenosis after balloon angioplasty. The Dose-Finding Study Group. N Engl J Med 2001; 344: 243-249.
37. Popowski Y, Verin V, Urban P et al. Intra-arterial yttrium-90 brachytherapy for restenosis prevention. In: Bruggmoser G, Mould RF, eds, Brachytherapy Review. Freiburg Oncology Series Monograph No. 1. Freiburg, Germany, Albert-Ludwigs-University, 1994: 163-165.
38. Popowski Y, Verin V, Papirov I et al. High dose rate brachytherapy for prevention of restenosis after percutaneous transluminal coronary angioplasty: preliminary dosimetric tests of a new source presentation. Int J Radiat Oncol Biol Phys 1995; 33: 211-215.
39. Popowski Y, Verin V, Papirov I et al. Intra-arterial 90-Y brachytherapy: preliminary dosimetric study using a specially modified angioplasty balloon. Int J Radiat Oncol Biol Phys 1995; 33: 713-717.
40. Popowski Y, Verin V, Schwager M et al. A novel system for intracoronary beta-irradiation: description and dosimetric results. Int J Radiat Oncol Biol Phys 1996; 36: 923-931.
41. Haase J, Escaned J, van Swijndregt EM et al. Experimental validation of geometric and densitometric coronary measurements on the new generation Cardiovascular Angiography Analysis System (CAAS II). Cathet Cardiovasc Diagn 1993; 30: 104-114.
42. Di Mario C, Hermans WR, Rensing BJ, Serruys PW. Calibration using angiographic catheters as scaling devices - importance of filming the catheters not filled with contrast medium. Am J Cardiol 1992; 69: 1377-1388.
43. Serruys PW, Foley DP, de Feyter PJ, Quantitative Coronary Angiography In Clinical Practice. Dordrecht/Boston/London, Kluwer Academic Publishers, 1994.
44. Kuntz RE, Speiser B, Joyal M et al. Clinical and angiographic outcomes after use of Sr-90 beta radiation for the treatment of de novo and restenotic coronary lesions. Presented at: Congress of the American College of Cardiology, Orlando, FL, USA, March 2001.
45. Weinberger J, Amols H, Ennis RD, Schwartz A, Wiedermann JG, Marboe C. Intracoronary irradiation: dose response for the prevention of restenosis in swine. Int J Radiat Oncol Biol Phys 1996; 36: 767-775.
46. Carter AJ, Laird JR, Bailey LR et al. Effects of endovascular radiation from a beta-particle-emitting stent in a porcine coronary restenosis model. A dose-response study. Circulation 1996; 94: 2364-2368.
47. Sabate M, Serruys PW, van der Giessen WJ et al. Geometric vascular remodeling after balloon angioplasty and beta-radiation therapy: a three-dimensional intravascular ultrasound study. Circulation 1999; 100: 1182-1188.
48. Hansen A, Hehrlein C, Hardt S et al. Is the 'candy-wrapper' effect of 32 P radioactive beta-emitting stents due to remodeling or neointimal hyperplasia? Insights from intravascular ultrasound. Cathet Cardiovasc Intervent 2001; 54: 41-48.
49. Dussaillant GR, Mintz GS, Pichard AD et al. Small stent size and intimal hyperplasia contribute to restenosis: a volumetric intravascular ultrasound analysis. J Am Coll Cardiol 1995; 26: 720-724.
50. Ikari Y, Hara K, Tamura T, Saeki F, Yamaguchi T. Luminal loss and site of restenosis after Palmaz-Schatz coronary stent implantation. Am J Cardiol 1995; 76: 117-120.
51. Hoffmann R, Mintz GS, Kent KM et al. Serial intravascular ultrasound predictors of restenosis at the margins of Palmaz-Schatz stents. Am J Cardiol 1997; 79: 951-953.
52. Leon MB, Moses JW, Popma RE. SIRIUS: the US multicenter, randomized, double-blind study of the Sirolimus-eluting stent in de novo, native coronary lesions. Presented at TCT Washington, DC, USA, September 2002.
53. Auch-Schwelk W, Moesseler S, Schopohl B et al. Geographic miss increases the risk of late target vessel thrombosis after intracoronary brachytherapy with beta radiation. Eur Heart J 2001; 22: 391 (abstr suppl).
54. Morice MC, Serruys PW, Sousa JE et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346: 1773-1780.
55. Lansky AJ. Comparative angiographic analysis of gamma and beta radiation: focus on efficacy impact of vessel size, lesion length and failure modes. Presented at TCT Washington, DC, USA, September 2001.
56. Degertekin M, Serruys PW, Foley DP et al. Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation: long-term (up to 2 years) clinical, angiographic, and intravascular ultrasound follow-up. Circulation 2002; 106: 1610-1613.